Current Drug Targets
Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Ranking and Category
-
131st of 267 in
Pharmacology & Pharmacy
Contents
Current Drug Targets, Volume 13 - Number 6
Editorial [Hot Topic: Pancreatic Cancer: Between Bench and Bedside (Guest Editors: Davide Melisi and Alfredo Budillon)]
, 13(6): 729 - 730Davide Melisi and Alfredo Budillon
DOI: 10.2174/138945012800564130
Molecular and Genetic Bases of Pancreatic Cancer
, 13(6): 731 - 743Vanja Vaccaro, Alain Gelibter, Emilio Bria, Pierluigi Iapicca, Paola Cappello, Francesca Di Modugno, Maria Simona Pino, Carmen Nuzzo, Francesco Cognetti, Francesco Novelli, Paola Nistico and Michele Milella
DOI: 10.2174/138945012800564077
Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside Translation
, 13(6): 744 - 752Vincenzo Corbo, Giampaolo Tortora and Aldo Scarpa
DOI: 10.2174/138945012800564103
Is Preoperative Endoscopic Biliary Drainage Indicated for Jaundiced Patients with Resectable Pancreatic Cancer?
, 13(6): 753 - 763Mario de Bellis, Raffaele Palaia, Claudia Sandomenico, Elena Di Girolamo, Marco Cascella and Francesco Fiore
DOI: 10.2174/138945012800564167
Pancreatic Cancer Surgery: The State of the Art
, 13(6): 764 - 771Song Cheol Kim, Young Hoon Kim, Kwang Min Park and Young Ju Lee
DOI: 10.2174/138945012800564185
Vascular Resection in Pancreaticoduodenectomy: Is it Worthwhile?
, 13(6): 772 - 780Francesco Bianco, Cinzia Sassaroli, Paolo Delrio, Silvia De Franciscis and Giovanni Romano
DOI: 10.2174/138945012800564121
Conventional Chemotherapy of Advanced Pancreatic Cancer
, 13(6): 795 - 801Francesco Giuliani, Massimo Di Maio, Giuseppe Colucci and Francesco Perrone
DOI: 10.2174/138945012800564149
Targeting EGFR in Pancreatic Cancer Treatment
, 13(6): 802 - 810T. Troiani, E. Martinelli, A. Capasso, F. Morgillo, Michele Orditura, F. De Vita and F. Ciardiello
DOI: 10.2174/138945012800564158
Systemic Therapies for Pancreatic Cancer - The Role of Pharmacogenetics
, 13(6): 811 - 828Ross A. Soo, Wei-Peng Yong and Federico Innocenti
DOI: 10.2174/138945012800564068
To Cardiovascular Disease and Beyond: New Therapeutic Perspectives of Statins in Autoimmune Diseases and Cancer
, 13(6): 829 - 841Chary Lopez-Pedrera, Patricia Ruiz-Limon, Araceli Valverde-Estepa, Nuria Barbarroja and Antonio Rodriguez-Ariza
DOI: 10.2174/138945012800564112
Adenosine Deaminase in the Modulation of Immune System and its Potential as a Novel Target for Treatment of Inflammatory Disorders
, 13(6): 842 - 862Luca Antonioli, Rocchina Colucci, Concettina La Motta, Marco Tuccori, Oriana Awwad, Federico Da Settimo, Corrado Blandizzi and Matteo Fornai
DOI: 10.2174/138945012800564095
Apixaban: A New Player in the Anticoagulant Class
, 13(6): 863 - 875Ritesh Agrawal, Pratima Jain and S. N. Dikshit
DOI: 10.2174/138945012800564059
  |
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA
View Full Editorial Board
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63
Advertisement
Webmaster Contact: info@benthamscience.net